Pinnacle Wealth Planning Services’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRWD
AC
SCM
VPM
VCM
Pinnacle Wealth Planning Services's IRWD Position: Q1 2026 in Review
Pinnacle Wealth Planning Services held its Ironwood Pharmaceuticals (IRWD) position steady in Q1 2026 at 201 shares worth $706. The position accounts for ﹤0.01% of the portfolio, ranked #2595.
Pinnacle Wealth Planning Services first reported a position in IRWD in Q4 2020 and has held it in 9 quarters since. The position peaked at $138K in Q3 2021. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.
- Pinnacle Wealth Planning Services held 201 shares of Ironwood Pharmaceuticals worth $706 as of Q1 2026.
- Pinnacle Wealth Planning Services left its Ironwood Pharmaceuticals share count unchanged in Q1 2026.
- Ironwood Pharmaceuticals made up ﹤0.01% of Pinnacle Wealth Planning Services's portfolio in Q1 2026, its #2595 holding.
- Pinnacle Wealth Planning Services first reported a position in Ironwood Pharmaceuticals in Q4 2020 and has held it in 9 quarters since.
- Pinnacle Wealth Planning Services's Ironwood Pharmaceuticals position peaked at $138K in Q3 2021.
- 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.
Based on Pinnacle Wealth Planning Services's 13F filing for Q1 2026, filed 11 May 2026.